arrow
C

Carlos Martínez-Rivera

hospital universitario germans trias i pujol
H指数:20
被引数:1,504

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit

ORBE II研究:根据气流阻塞状况和吸烟习惯,接受贝那利珠单抗治疗后的临床特征与结局

2025-11-070
OAAI
Stability of Asthma Biomarkers Over a Two-year Period Using Three Distinct Classifications in the MEGA Cohort

哮喘生物标志物在两年期间内的稳定性:MEGA队列中三种不同分类的应用

2025-07-050
PRE
Evaluating the Utility of Biologic Therapies in Patients With Severe Asthma and Comorbid Bronchiectasis: A Systematic Review With Meta-analysis of Retrospective Studies

Garcia-Olivé, I.; Radua, J.; Biette, A.H.; Bruguera, N.; Berenguer, D.S.; Rivera, C.M. 评估严重哮喘伴支气管扩张症患者生物制剂治疗的效用:一项回顾性研究的系统评价与Meta分析。Arch. Bronconeumol. 2025, 26.(英文,西班牙文)。[Google Scholar] [CrossRef] [PubMed]

2025-04-260
PRE
Genome-wide Association Study of Asthma Exacerbations in the Spanish Population

哮喘急性发作的西班牙人群全基因组关联研究

2025-03-200
PREAI
Real-world effectiveness of switching to Benralizumab in patients with severe asthma in the Catalan population. Catalan Society of Pulmonology (SOCAP) Registry
2024-10-300
PRE
PBF-680, an oral A1 adenosine receptor antagonist, increases trough forced expiratory volume in 1 second (FEV1) in mild-to-moderate asthma: a Phase-II trial
2024-10-300
PRE
Comparison of the Determinants of the Chronic Obstructive Pulmonary Disease Assessment Test (CAT) and the Asthma Control Test (ACT) in Patients with Asthma-COPD Overlap

哮喘-COPD重叠患者的慢性阻塞性肺疾病评估测试 (CAT) 和哮喘控制测试 (ACT) 的决定因素比较

2024-10-240
OAAI
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

在严重哮喘患者的现实队列中,使用不同标准比较奥马珠单抗和Anti-IL-5/IL-5R的长期反应和缓解

2024-01-014
OA
Reply to Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies

对嗅觉功能和生物治疗的回复: 对现有现实生活研究的评论

2023-12-130
OA
Therapeutic Goals and Treatable Traits: Long-Term Trends in a Severe Asthma Population
2023-12-010
OAAI
Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study
2023-12-017
PRE
Disposition of Work-Related Asthma in a Spanish Asthma Cohort: Comparison of Asthma Severity Between Employed and Retired Workers

西班牙哮喘队列中与工作相关的哮喘的处置: 在职和退休工人之间哮喘严重程度的比较

2023-11-014
OAAI
Efficacy of benralizumab and mepolizumab in treating severe eosinophilic asthma: A one-year study on clinical remission and response

贝那利珠单抗和美泊利单抗治疗重度嗜酸性粒细胞性哮喘的疗效: 一项为期一年的临床缓解和反应研究

2023-10-271
PRE